Statin therapy: more than meets the eye?
نویسنده
چکیده
W hen Gertrude Stein famously wrote, “Rose is a rose is a rose is a rose,” she seemed to reveal an ignorance of, if not contempt for, the flowers. After all, any gardener knows some roses look like flabby cabbages and others sport flesh-ripping thorns. Do physicians, MCOs, and PBMs who act as though “statin is a statin is a statin is a statin”display a similarly uncritical attitude toward the drugs — and unwittingly show a certain disregard for their patients? Or are statins (and roses) really rather more similar than not? Back in the early days of statin therapy, circa 1990, the notion of reducing the risk of morbidity and mortality from heart disease by lowering levels of cholesterol was still greeted with some skepticism. Cholesterol, after all, is a component of every human cell. It was thought that overly aggressive cholesterol reduction might trigger cancer or some kind of central nervous disorder. But since then several large clinical trials (See “Major statin trials”on page 41) seem to have established the overall safety and clinical value of statins. Their best-known effect is reducing the amount of cholesterol carried by low-density lipoprotein (LDL), thereby preventing the accumulation of LDL cholesterol (LDL-c) in atherosclerotic plaque. Today, LDL-c reduction is well accepted as a means of reducing cardiovascular risk, and the manufacturers of a half dozen statins vie for the attention of physicians, patients, and P&T committees — and a chunk of the $13.5 billion U.S. statin market. The entire market is supported by guidelines issued by the National Cholesterol Education Program (NCEP), which recommends statin therapy for patients at risk for coronary heart disease (CHD), and which physicians ignore at their legal peril. Armed with scientific studies — plus plenty of marketing savvy — each statin manufacturer seeks to demonstrate why its product should be preferred over the competition. If you haven’t yet heard presentations about the effects of statins on high-density lipoprotein cholesterol (HDL-c) and inflammation, as measured by highsensitivity C-reactive protein (hs-CRP), you soon will. At the same time, all the statin manufacturers keep looking over their shoulder for the coming of the next blockbuster in cardiovascular drug therapy. It probably won’t be yet another statin, but it might be one or more products that improve levels of HDL-c. HDL is best known for its ability to transport cholesterol away from peripheral tissues, thereby reducing the cholesterol burden in atherosclerotic plaque.
منابع مشابه
بار درمان استاتین در جمعیت شهری ایران بر اساس راهنمای بالینی جدید ACC/AHA
Background: In Nov 2013, the instruction for controlling high cholesterol has been released by the American College of Cardiology (ACC) and the American Heart Association (AHA) which need to be assessed in the different communities. Methods: Of total 6275 individual aged 40-75 years who entered at the Tehran Lipids and Glucose Study from March 1999 to 20 March 2010 in first examination cycle, ...
متن کاملEffects of Defining Realistic Compositions of the Ocular Melanoma on Proton Therapy
Background: Recent studies in eye plaque brachytherapy have shown a considerable difference between the dosimetric results using water phantom and a model of human eye containing realistic materials. In spite of this fact, there is a lack of simulation studies based on such a model in proton therapy literatures. In the presented work, the effect of utilizing an eye model with ocular media on pr...
متن کاملCorticotherapy in Eye Diseases and Its Complications
Corticosteroids are being rn;;ed in different ophthalmic disorder as anti-inflamatory agent. A.C.T.H. stimulated the supra renal glands and causes an increase steroid concentration of the blood. Corticosteroids can be used as antiinflamatory agent locally ar.d systemically. The new corticom,teroids like prednison, dexxametason and prednisolon are more effective ( 5 to 10 times) than the o...
متن کاملMore than meets the eye.
Thank you for reading more than meets the eye. Maybe you have knowledge that, people have search numerous times for their chosen books like this more than meets the eye, but end up in infectious downloads. Rather than reading a good book with a cup of coffee in the afternoon, instead they cope with some malicious virus inside their computer. more than meets the eye is available in our book coll...
متن کاملElectrophysiologic and clinico-pathologic characteristics of statin-induced muscle injury
Objective(s):In this study, we aimed at evaluation of electrophysiological and histopathalogical characteristics of statin-induced muscle injury as well as clinical features of patients who develop this condition in terms of frequency and pattern of evolution. Materials and Methods: Forty patients (age 39-74 years) including 25 subjects with type 2 diabetes mellitus, 9 with cardiovascular disea...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Managed care
دوره 13 4 شماره
صفحات -
تاریخ انتشار 2004